MIMOSA Diagnostics is a leading mHealth innovator building the next generation of patient monitoring and assessment tools. Driven by AI and delivered through the cloud, MIMOSA uses multi-spectral mobile tissue analysis to go beyond anatomy and assess the physiology of tissue health. Through real-time insights into tissue conditions and viability, MIMOSA improves remote monitoring and assessment, enabling better treatment decisions and outcomes for each patient.
Investment year: 2018
Industry sector: Medical/health